A review of chitosan polysaccharides: Neuropharmacological implications and tissue regeneration.

One of the current challenges in targeting neurological disorders is that many therapeutic molecules cannot cross the blood-brain barrier (BBB), which limits the use of natural molecules in nervous tissue regeneration. Thus, the development of new drugs to effectively treat neurological disorders would be a challenge. Natural resources are well known as a source of several therapeutic agents for the treatment of neurologic disorders. Recently, chitosan (CTS) and its derivatives from arthropod exoskeletons, have attracted much attention as a drug delivery system to transport therapeutic substances across the BBB and thanks to other neuroprotective effects including the participation to the CNS regenerations scaffolds to replicate the extracellular matrix and microenvironment of the body. This review will discuss the place of natural resource therapy in targeting neurological disorders. In particular, it will highlight recent understanding and progress in the applications of CTS as drug delivery systems and their therapeutic effects on these disorders through tissue regeneration, as well as the molecular mechanisms by which they exert these effects.

Exploring the potential of chitosan from royal shrimp waste for elaboration of chitosan/bioglass biocomposite: Characterization and "in vitro" bioactivity.

Exploiting royal shrimp waste to produce value-added biocomposites offers environmental and therapeutic benefits. This study proposes biocomposites based on chitosan and bioglass, using shrimp waste as the chitosan source. Chitin extraction and chitosan preparation were characterized using various analytical techniques. The waste composition revealed 24 % chitin, convertible to chitosan, with shells containing 77.33-ppm calcium. (X-ray diffraction) XRD analysis showed crystallinity index of 54.71 % for chitin and 49.14 % for chitosan. Thermal analysis indicated degradation rates of 326 °C and 322 °C, respectively. The degree of deacetylation of chitosan was 97.08 % determined by proton nuclear magnetic resonance (1H-NMR) analysis, with an intrinsic viscosity of 498 mL.g-1 and molar mass of 101,720 g/mol, showing improved solubility in 0.3 % acetic acid. Royal chitosan (CHR) was combined with bioglass (BG) via freeze-drying to create a CHR/BG biocomposite for bone surgery applications. The bioactivity of the CHR/BG was tested in simulated body fluid (SBF), revealing a biologically active apatite layer on its surface. Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES) analysis confirmed enhanced bioactivity of the CHR/BG compared to commercial chitosan. The CHR/BG biocomposite demonstrated excellent apatite formation, validated by Scanning Electron Microscopy (SEM), highlighting its potential in bone surgery.

Exploring the potential of chitosan/aragonite biocomposite derived from cuttlebone waste: Elaboration, physicochemical properties and in vitro bioactivity.

Cuttlefish bone biowaste is a potential source of a composite matrix based on chitin and aragonite. In the present work, we propose for the first time the elaboration of biocomposites based on chitosan and aragonite through the valorization of bone waste. The composition of the ventral and dorsal surfaces of bone is well studied by ICP-OES. An extraction process has been applied to the dorsal surface to extract ß-chitin and chitosan with controlled physico-chemical characteristics. In parallel, aragonite isolation was carried out on the ventral side. The freeze-drying method was used to incorporate aragonite into the chitosan polymer to form CHS/ArgS biocomposites. Physicochemical characterizations were performed by FT-IR, SEM, XRD, 1H NMR, TGA/DSC, potentiometry and viscometry. The ICP-OES method was used to evaluate in vitro the bioactivity level of biocomposite in simulated human plasma (SBF), enabling analysis of the interactions between the material and SBF. The results obtained indicate that the CHS/ArgS biocomposite derived from cuttlefish bone exhibits bioactivity, and that chitosan enhances the bioactivity of aragonite. The CHS/ArgS biocomposite showed excellent ability to form an apatite layer on its surface. After three days' immersion, FTIR and SEM analyses confirmed the formation of this layer.

Investigation on Akis granulifera (Coleoptera, Sahlberg, 1823) as a potential source of chitin and chitosan: Extraction, characterization and hydrogel formation.

The majority of studies have focused on the industrial exploitation of marine fisheries waste through the production of natural bioactive bioploymeres such as chitin and chitosan. However, in recent years, beetles are increasingly attracting the interest of scientists as a source of chitin and chitosan for the preparation of hydrogels for sustainable engineering development. In the present work, we focus on the study for the first time a new Moroccan species of beetle (Akis granulifera Sahlberg, 1823), for the extraction of chitin and the elaboration of chitosan. A chemical extraction process was used. Then, physicochemical characterizations by FT-IR, SEM, XRD, 1H NMR, TGA/DSC, Potentiometry, Viscosimetry, and elemental analysis were performed. In addition, to evaluate its physicochemical quality, the elaborated chitosan is combined with alginate to form a hydrogel. This hydrogel was effectively characterized by SEM, DRX and FTIR to show the potential of chitosan from Akis granulifera in biomaterial applications.